References
- Altschule MD. The two kinds of depression according to St. Paul. BE J: fiychiatry113, 779–780 (1967).
- Boyce P, Hadzi-Pavlovic D. Issues in classification: I. Some historical aspects. In: Melancholia: A Disorder of Movement, and Mood. A Phenomenological and Neurobiological Review Parker G, Hadzi-Pavlovic D (Eds), Cambridge University Press, New York, USA, 9–19 (1996).
- Mapother E. Manic-depressive psychosis. BE Med 2,872–877 (1926).
- Lewis A. Melancholia: a clinical survey of depressive states. J: Ment. Sri. 80,277–378 (1934).
- Gillespie RD. The clinical differentiation of types of depression. Guy's Hospital Report2, 306–344 (1929).
- Parker G, Hadzi-Pavlovic D. Boyce P Issues in classification: II. Classifying melancholia In: 1141ancholia: A Disoirler of Movement, and Mood A Phenomenological and Neumbiological Review Parker G, Hadzi-Pavlovic D (Eds), Cambridge University Press, New York, USA, 20–37 (1996).
- Paykel ES. Classification of depressed patients: a cluster analysis derived grouping. Br. Psychiatry118, 275–288 (1971).
- Fairchild CJ, Rush AJ, Vasavada N, Giles DE, Khatami M. Which depressions respond to placebo? Psychiatry Res. 18, 217–226 (1986).
- Parker G, Hadzi-Pavlovic D. Melancholia: A Disarler of Movement and Mood. A Phenomenological and Neurobiological Review Cambridge University Press, New York, USA, (1996).
- •An historical overview of melancholia and a detailed exposition arguing for melancholia having a 'necessary and sufficient' feature of psychomotor disturbance defining its subtype phenotypic expression and detailing the CORE measure of 'melancholia'.
- Austin M-P, Mitchell P. Melancholia as a Neurological Disorder. In Melancholia: A Disarler of Movement, and Mood. A Phenomenological and Neurobiological Review Parker G, Hadzi-Pavlovic D (Eds), Cambridge University Press, New York, USA, 223–236 (1996).
- Agency for Healthcare Policy and Research: Clinical Practice Guideline: Depression in Primary Care, vol 2: Treatment of Major Depression. AHCPR Publication 93–0551. Washington, DC, US Government Printing Office, (1993).
- Parker G, Hickie I, Mason, C. Validity of the CORE measure: III. Outcome and treatment prediction. In: Melancholia: A Disorder of Movement, and Mood. A Phenomenological and Neurobiological Review Parker G, Hadzi-Pavlovic D (Eds), Cambridge University Press, New York, USA, 160–171 (1996).
- Rush AJ, Weissenburger JE. Melancholic symptom features: a review and options for DSM-IV. In: DSM-IVSource Rook. Volume 2. Widiger TA, Frances AJ, Pincus MA, Ross R, First MB, David W (Eds), American Psychiatric Press, Washington, DC, USA (1995).
- Parker G. Editorial. 'New' and 'old' antidepressants: all equal in the eyes of the lore? Br. PTchiatry179, 95–95 (2001).
- •• This editorial summarises studies examining the increasing clinical impression that the newer narrow action drugs may not be so effective as the older broad action antidepressants and offers an explanatory reason.
- APA Practice Guidelines for the Treatment of Psychiatric Disorrlers, Compendium 2000. American Psychiatric Association, Washington DC, USA (2000).
- Parker G, Roy K, Hadzi-Pavlovic D, Wilhelm K, Mitchell P. The differential impact of age on the phenomenology of melancholia. Bychol Med. 31, 1231–1236. (2001).
- •This paper provides data to suggest that the phenotypic picture of 'melancholia' changes with age — and not merely with duration of illness. The changed phenotypic picture may assist explaining why narrow and broad action antidepressant drugs may be of differing effectiveness in melancholia and why some antidepressants 'poop out' after a period.
- Parker G, Malhi G. Are atypical antidepressant drugs also atypical antidepressants? ANZJ Psychiatry35, 631–638. (2001).
- ••Important in being one of only three papers (two case series and one small controlled trial) suggesting that the atypical antipsychotic drugs may have distinct augmenting potential — in enhancing the action of antidepressant drugs that have failed to induce a remission.